Automation Mag

OCTOBER 17, 2024

percent between 2024 and 2029, with $1.1 billion in sales projected for 2029. percent forecast from 2023 to 2029. By 2029, the market size is projected to be worth more than $80 million, notes the firm. percent in 2024 due to sluggish machinery production and reduced investment in the battery sector. percent in 2024.

Electronics 59

Electronics Pharmaceutical Smart manufacturing Automation 59

Gary Mintchell

NOVEMBER 15, 2024

By 2029, sales of linear systems are expected to exceed $1.1 Since Interact Analysis began tracking smart conveyance market data in 2020, the food, pharmaceutical and general packaging industries were the main application markets for smart conveyance systems until 2022. billion, nearly five times the market size in 2020.

Robotics 130

Robotics Robotics Automation Pharmaceutical 130

AU Manufacturing

FEBRUARY 14, 2023

million for a further seven years, or until 2029, to continue its support for life science investment fund Brandon BioCatalyst , to which it has given $2.52 million to Brandon BioCatalyst for the period 2008-2029 with the hope of nurturing ground-breaking WA biomedical discoveries,” said Medical Research Minister Stephen Dawson.

Pharmaceutical 52

Pharmaceutical Manufacturing 52

Robotics Business Review

JUNE 20, 2024

The report also found that 61% of manufacturers expect artificial intelligence to drive growth by 2029, up from 41% in 2024. They included automotive, electronics, food and beverage, pharmaceuticals, and medical devices. Zebra commissioned Azure Knowledge Corp.

Manufacturing 106

Manufacturing Supply Chain Robotics Robotics 106

Robotics Business Review

NOVEMBER 3, 2024

By 2029, sales of linear systems could exceed $1.1 Since the research firm began tracking smart conveyance market data in 2020, the food , pharmaceutical , and general packaging industries were the main application markets for such conveyance systems. billion, nearly five times the market size in 2020, according to Interact Analysis.

Robotics 59

Robotics Robotics Automation Pharmaceutical 59

Frost & Sullivan Manufacturing

JUNE 24, 2024

The key imperatives for oncology industry stakeholders includes: Collaboration between pharmaceutical companies, the government, academics, and diagnostics providers are crucial for personalized medicine adoption and development.

Artificial Intelligence 52

Artificial Intelligence Pharmaceutical 52